ORN (NYSE: ORN) amendment lists 90,000 common shares for resale
Rhea-AI Filing Summary
Raymond James & Associates filed an amendment on Form 144/A reporting proposed sales of $1,060,200.00 tied to 90,000 common shares of ORN listed on NYSE.
The filing states the shares were acquired as compensation on 09/12/2022 (RSUs) and identifies the broker and address. The amendment updates prior sale information as of 03/10/2026.
Positive
- None.
Negative
- None.
Insights
Form 144/A records a broker-mediated resale notice for 90,000 ORN shares.
The filing lists 90,000 common shares and an aggregate dollar amount of $1,060,200.00, reflecting proposed disposition by a broker, Raymond James & Associates. The shares are described as issued for compensation (RSUs) on 09/12/2022.
Cash-flow treatment and planned sale mechanics are not detailed in the excerpt; subsequent trading depends on holder/broker execution and any sale limitations disclosed elsewhere.
This amendment updates previously reported resale details and broker contact info.
Form 144/A amendments typically correct or supplement earlier sale notices; this entry supplies broker name, address, and the amended numeric values including 90,000 shares and $1,060,200.00. The filing date shown is 03/10/2026.
Regulatory significance is procedural: it documents the proposed disposition; any legal or lock-up constraints are not disclosed in the provided excerpt.